1888P 24-month follow up of durvalumab and savolitinib combination in MET-driven clear cell and non-clear cell renal cancer
Annals of Oncology(2023)
关键词
renal cancer,durvalumab,savolitinib combination,met-driven,non-clear
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要